ALVO – alvotech (US:NASDAQ)
Stock Stats
News
Statutory Earnings May Not Be The Best Way To Understand Alvotech's (NASDAQ:ALVO) True Position [Yahoo! Finance]
Alvotech (ALVO) had its price target lowered by UBS Group AG from $10.00 to $6.00. They now have a "buy" rating on the stock.
Alvotech (ALVO) had its price target lowered by Barclays PLC from $5.00 to $4.00. They now have an "underweight" rating on the stock.
Alvotech (ALVO) was upgraded by Zacks Research from "strong sell" to "hold".
Did Alvotech's (ALVO) Profitability Turn and Expanding Biosimilar Pipeline Just Recast Its Investment Narrative? [Yahoo! Finance]
Form 6-K Alvotech For: Dec 31
Form SCHEDULE 13D/A Alvotech Filed by: Aztiq Pharma Partners S.a r.l.
Form 6-K Alvotech For: Feb 27
Form 6-K Alvotech For: Feb 05
Form 6-K Alvotech For: Feb 02
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.